Page 1

Johnson & Johnson News Release Media Contacts : Jake Sargent +1 732-524-1090 JSargen3@its.jnj.com Investor Relations : Jennifer McIntyre +1 732-524-3922 JMcInty3@its.jnj.com Johnson & Johnson Announces Plans to Accelerate Innovation , Serve Patients and Consumers , and Unlock Value through Intent to Separate Consumer Health Business New Consumer Health Company would be a Global Leader with Iconic Brands and Products that Touch Over One Billion Lives Every Day Johnson & Johnson would Remain a Global Leader in Healthcare , Focused on Major Unmet Medical Needs and Materially Advancing Standard of Care through Biopharmaceutical and Medical Device Innovation and Technology Separation Designed to Enhance Operational Performance and Strategic Flexibility , Benefiting Patients and Consumers and Unlocking Value for All Stakeholders New Consumer Health Company Expected to Complete Separation in 18 to 24 Months Johnson & Johnson to Host Investor Conference Call Today at 8:30 a.m. ET NEW BRUNSWICK , N.J. November 12 , 2021- Johnson & Johnson ( the " Company " ) ( NYSE : JNJ ) today announced its intent to separate the Company's Consumer Health business , creating a new publicly traded company . The planned separation would create two global leaders that are better positioned to deliver improved health outcomes for patients and consumers through innovation , pursue more targeted business strategies and accelerate growth . Following the planned separation , the new Johnson & Johnson would remain the world's largest and most diverse healthcare company and continue its commitment to lead in global healthcare R & D and innovation , with a portfolio that blends its strong Pharmaceutical and Medical Device capabilities focused on advancing the standard of care through innovation and technology . As previously announced , Mr. Alex Gorsky will serve as Executive Chairman of